Most Recent Articles by Laura Stiles
Lofexidine may expand the treatment options available for managing withdrawal when buprenorphine and methadone are unavailable or undesirable.
Borderline personality disorder, a disorder that is often misunderstood by the general public, also raises questions for psychiatrists.
At 6 weeks of treatment, severely ill patients treated with adjunctive brexpiprazole had a greater reduction in PANSS total scores and CGI-S scores compared with those receiving placebo.
This research provides further support to compelling data linking inflammation and depression.
The researchers believe this study is the first to detect a statistically significant, unexpected inverse association between efavirenz use and depression.
More Articles by Laura Stiles
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Role of Expressed Emotion in Family Psychopathology
- Serum Uric Acid May Predict Bipolar Disorder in Patients With Depression
- Health and Social Factors Predict Changes in Depressive Symptoms in Women
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- ASD Risk on Offspring With Prenatal Use of Medication Affecting Neurotransmitter System
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Effects of Mindfulness Meditation on Mood in Middle-Age, Older Adults
- How Does Accepting Blame Affect Future Medical Errors?
- Dementia Often Misclassified With Brief Cognitive Assessments
- Vitamin D Deficiency May Contribute to Elevated Interleukin-6 in Psychosis